The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Delirium Treatment Drugs Market Research Report 2025
Synopsis
The global Delirium Treatment Drugs market was valued at US$ 275 million in 2023 and is anticipated to reach US$ 427.1 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
North American market for Delirium Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Delirium Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Delirium Treatment Drugs include Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc and Fraser Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Delirium Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Delirium Treatment Drugs.
Report Scope
The Delirium Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Delirium Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Delirium Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V.
Pfizer Inc.
Novartis AG
Gala BioPharma Ltd.
Teva pharmaceuticals
Dr Franz Kohler Chemie GmbH
Bristol-Myers Squibb
Regenstrief Institute Inc
Fraser Health
Otsuka Pharmaceutical Co. Ltd.
Zydus Cadila
Segment by Type
Oral
Injection
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Delirium Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Delirium Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Delirium Treatment Drugs market was valued at US$ 275 million in 2023 and is anticipated to reach US$ 427.1 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
North American market for Delirium Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Delirium Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Delirium Treatment Drugs include Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc and Fraser Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Delirium Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Delirium Treatment Drugs.
Report Scope
The Delirium Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Delirium Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Delirium Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan N.V.
Pfizer Inc.
Novartis AG
Gala BioPharma Ltd.
Teva pharmaceuticals
Dr Franz Kohler Chemie GmbH
Bristol-Myers Squibb
Regenstrief Institute Inc
Fraser Health
Otsuka Pharmaceutical Co. Ltd.
Zydus Cadila
Segment by Type
Oral
Injection
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Delirium Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Delirium Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Delirium Treatment Drugs Market Overview
1.1 Product Overview and Scope of Delirium Treatment Drugs
1.2 Delirium Treatment Drugs Segment by Type
1.2.1 Global Delirium Treatment Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Delirium Treatment Drugs Segment by Application
1.3.1 Global Delirium Treatment Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Delirium Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Delirium Treatment Drugs Revenue 2019-2030
1.4.2 Global Delirium Treatment Drugs Sales 2019-2030
1.4.3 Global Delirium Treatment Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Delirium Treatment Drugs Market Competition by Manufacturers
2.1 Global Delirium Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Delirium Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Delirium Treatment Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Delirium Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Delirium Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Delirium Treatment Drugs, Product Type & Application
2.7 Delirium Treatment Drugs Market Competitive Situation and Trends
2.7.1 Delirium Treatment Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Delirium Treatment Drugs Players Market Share by Revenue
2.7.3 Global Delirium Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Delirium Treatment Drugs Retrospective Market Scenario by Region
3.1 Global Delirium Treatment Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Delirium Treatment Drugs Global Delirium Treatment Drugs Sales by Region: 2019-2030
3.2.1 Global Delirium Treatment Drugs Sales by Region: 2019-2024
3.2.2 Global Delirium Treatment Drugs Sales by Region: 2025-2030
3.3 Global Delirium Treatment Drugs Global Delirium Treatment Drugs Revenue by Region: 2019-2030
3.3.1 Global Delirium Treatment Drugs Revenue by Region: 2019-2024
3.3.2 Global Delirium Treatment Drugs Revenue by Region: 2025-2030
3.4 North America Delirium Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Delirium Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Delirium Treatment Drugs Sales by Country (2019-2030)
3.4.3 North America Delirium Treatment Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Delirium Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Delirium Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Delirium Treatment Drugs Sales by Country (2019-2030)
3.5.3 Europe Delirium Treatment Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Delirium Treatment Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Delirium Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Delirium Treatment Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Delirium Treatment Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Delirium Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Delirium Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Delirium Treatment Drugs Sales by Country (2019-2030)
3.7.3 Latin America Delirium Treatment Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Delirium Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Delirium Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Delirium Treatment Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Delirium Treatment Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Delirium Treatment Drugs Sales by Type (2019-2030)
4.1.1 Global Delirium Treatment Drugs Sales by Type (2019-2024)
4.1.2 Global Delirium Treatment Drugs Sales by Type (2025-2030)
4.1.3 Global Delirium Treatment Drugs Sales Market Share by Type (2019-2030)
4.2 Global Delirium Treatment Drugs Revenue by Type (2019-2030)
4.2.1 Global Delirium Treatment Drugs Revenue by Type (2019-2024)
4.2.2 Global Delirium Treatment Drugs Revenue by Type (2025-2030)
4.2.3 Global Delirium Treatment Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Delirium Treatment Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Delirium Treatment Drugs Sales by Application (2019-2030)
5.1.1 Global Delirium Treatment Drugs Sales by Application (2019-2024)
5.1.2 Global Delirium Treatment Drugs Sales by Application (2025-2030)
5.1.3 Global Delirium Treatment Drugs Sales Market Share by Application (2019-2030)
5.2 Global Delirium Treatment Drugs Revenue by Application (2019-2030)
5.2.1 Global Delirium Treatment Drugs Revenue by Application (2019-2024)
5.2.2 Global Delirium Treatment Drugs Revenue by Application (2025-2030)
5.2.3 Global Delirium Treatment Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Delirium Treatment Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan N.V.
6.1.1 Mylan N.V. Corporation Information
6.1.2 Mylan N.V. Description and Business Overview
6.1.3 Mylan N.V. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan N.V. Delirium Treatment Drugs Product Portfolio
6.1.5 Mylan N.V. Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Corporation Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc. Delirium Treatment Drugs Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Delirium Treatment Drugs Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Gala BioPharma Ltd.
6.4.1 Gala BioPharma Ltd. Corporation Information
6.4.2 Gala BioPharma Ltd. Description and Business Overview
6.4.3 Gala BioPharma Ltd. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolio
6.4.5 Gala BioPharma Ltd. Recent Developments/Updates
6.5 Teva pharmaceuticals
6.5.1 Teva pharmaceuticals Corporation Information
6.5.2 Teva pharmaceuticals Description and Business Overview
6.5.3 Teva pharmaceuticals Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva pharmaceuticals Delirium Treatment Drugs Product Portfolio
6.5.5 Teva pharmaceuticals Recent Developments/Updates
6.6 Dr Franz Kohler Chemie GmbH
6.6.1 Dr Franz Kohler Chemie GmbH Corporation Information
6.6.2 Dr Franz Kohler Chemie GmbH Description and Business Overview
6.6.3 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolio
6.6.5 Dr Franz Kohler Chemie GmbH Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Regenstrief Institute Inc
6.8.1 Regenstrief Institute Inc Corporation Information
6.8.2 Regenstrief Institute Inc Description and Business Overview
6.8.3 Regenstrief Institute Inc Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolio
6.8.5 Regenstrief Institute Inc Recent Developments/Updates
6.9 Fraser Health
6.9.1 Fraser Health Corporation Information
6.9.2 Fraser Health Description and Business Overview
6.9.3 Fraser Health Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fraser Health Delirium Treatment Drugs Product Portfolio
6.9.5 Fraser Health Recent Developments/Updates
6.10 Otsuka Pharmaceutical Co. Ltd.
6.10.1 Otsuka Pharmaceutical Co. Ltd. Corporation Information
6.10.2 Otsuka Pharmaceutical Co. Ltd. Description and Business Overview
6.10.3 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolio
6.10.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
6.11 Zydus Cadila
6.11.1 Zydus Cadila Corporation Information
6.11.2 Zydus Cadila Delirium Treatment Drugs Description and Business Overview
6.11.3 Zydus Cadila Delirium Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zydus Cadila Delirium Treatment Drugs Product Portfolio
6.11.5 Zydus Cadila Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Delirium Treatment Drugs Industry Chain Analysis
7.2 Delirium Treatment Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Delirium Treatment Drugs Production Mode & Process
7.4 Delirium Treatment Drugs Sales and Marketing
7.4.1 Delirium Treatment Drugs Sales Channels
7.4.2 Delirium Treatment Drugs Distributors
7.5 Delirium Treatment Drugs Customers
8 Delirium Treatment Drugs Market Dynamics
8.1 Delirium Treatment Drugs Industry Trends
8.2 Delirium Treatment Drugs Market Drivers
8.3 Delirium Treatment Drugs Market Challenges
8.4 Delirium Treatment Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Delirium Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Delirium Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Delirium Treatment Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Delirium Treatment Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Delirium Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Delirium Treatment Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Delirium Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Delirium Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Delirium Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Delirium Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Delirium Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Delirium Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Delirium Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Delirium Treatment Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Delirium Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Delirium Treatment Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Delirium Treatment Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Delirium Treatment Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Delirium Treatment Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Delirium Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Delirium Treatment Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Delirium Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Delirium Treatment Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Delirium Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Delirium Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Delirium Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Delirium Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Delirium Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Delirium Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Delirium Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Delirium Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Delirium Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Delirium Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Delirium Treatment Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Delirium Treatment Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Delirium Treatment Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Delirium Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Delirium Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Delirium Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Delirium Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Delirium Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Delirium Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Delirium Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Delirium Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Delirium Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Delirium Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Delirium Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Delirium Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Delirium Treatment Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Delirium Treatment Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Delirium Treatment Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Delirium Treatment Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Delirium Treatment Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Delirium Treatment Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Delirium Treatment Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Delirium Treatment Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Delirium Treatment Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Delirium Treatment Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Delirium Treatment Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Delirium Treatment Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Delirium Treatment Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Delirium Treatment Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Delirium Treatment Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Delirium Treatment Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Mylan N.V. Corporation Information
Table 71. Mylan N.V. Description and Business Overview
Table 72. Mylan N.V. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Mylan N.V. Delirium Treatment Drugs Product
Table 74. Mylan N.V. Recent Developments/Updates
Table 75. Pfizer Inc. Corporation Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Inc. Delirium Treatment Drugs Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis AG Delirium Treatment Drugs Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Gala BioPharma Ltd. Corporation Information
Table 86. Gala BioPharma Ltd. Description and Business Overview
Table 87. Gala BioPharma Ltd. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Gala BioPharma Ltd. Delirium Treatment Drugs Product
Table 89. Gala BioPharma Ltd. Recent Developments/Updates
Table 90. Teva pharmaceuticals Corporation Information
Table 91. Teva pharmaceuticals Description and Business Overview
Table 92. Teva pharmaceuticals Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Teva pharmaceuticals Delirium Treatment Drugs Product
Table 94. Teva pharmaceuticals Recent Developments/Updates
Table 95. Dr Franz Kohler Chemie GmbH Corporation Information
Table 96. Dr Franz Kohler Chemie GmbH Description and Business Overview
Table 97. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product
Table 99. Dr Franz Kohler Chemie GmbH Recent Developments/Updates
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bristol-Myers Squibb Delirium Treatment Drugs Product
Table 104. Bristol-Myers Squibb Recent Developments/Updates
Table 105. Regenstrief Institute Inc Corporation Information
Table 106. Regenstrief Institute Inc Description and Business Overview
Table 107. Regenstrief Institute Inc Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Regenstrief Institute Inc Delirium Treatment Drugs Product
Table 109. Regenstrief Institute Inc Recent Developments/Updates
Table 110. Fraser Health Corporation Information
Table 111. Fraser Health Description and Business Overview
Table 112. Fraser Health Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Fraser Health Delirium Treatment Drugs Product
Table 114. Fraser Health Recent Developments/Updates
Table 115. Otsuka Pharmaceutical Co. Ltd. Corporation Information
Table 116. Otsuka Pharmaceutical Co. Ltd. Description and Business Overview
Table 117. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product
Table 119. Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 120. Zydus Cadila Corporation Information
Table 121. Zydus Cadila Description and Business Overview
Table 122. Zydus Cadila Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Zydus Cadila Delirium Treatment Drugs Product
Table 124. Zydus Cadila Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Delirium Treatment Drugs Distributors List
Table 128. Delirium Treatment Drugs Customers List
Table 129. Delirium Treatment Drugs Market Trends
Table 130. Delirium Treatment Drugs Market Drivers
Table 131. Delirium Treatment Drugs Market Challenges
Table 132. Delirium Treatment Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Delirium Treatment Drugs
Figure 2. Global Delirium Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Delirium Treatment Drugs Market Share by Type in 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Delirium Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Delirium Treatment Drugs Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Global Delirium Treatment Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Delirium Treatment Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Delirium Treatment Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Delirium Treatment Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Delirium Treatment Drugs Report Years Considered
Figure 16. Delirium Treatment Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Delirium Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Delirium Treatment Drugs Players: Market Share by Revenue in 2023
Figure 19. Delirium Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Delirium Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Delirium Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Delirium Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Delirium Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Delirium Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Delirium Treatment Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Delirium Treatment Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Delirium Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 42. Latin America Delirium Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Delirium Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Delirium Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Delirium Treatment Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Delirium Treatment Drugs by Type (2019-2030)
Figure 54. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Delirium Treatment Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Delirium Treatment Drugs by Application (2019-2030)
Figure 57. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Delirium Treatment Drugs Value Chain
Figure 59. Delirium Treatment Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
